Coincubation of CD8+ CTLs from DT-treated CML mice even further reduced the clonogenic potential of LSCs compared with CD8+ CTLs from PBS-treated CML mice (Figure 5G). The gene discussed is CD8A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.